Northern Trust Corp Raises Stock Holdings in Phreesia, Inc. (NYSE:PHR)

Northern Trust Corp boosted its position in Phreesia, Inc. (NYSE:PHR - Free Report) by 6.6% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 571,807 shares of the company's stock after purchasing an additional 35,392 shares during the period. Northern Trust Corp owned about 0.98% of Phreesia worth $14,387,000 as of its most recent SEC filing.

A number of other large investors have also recently made changes to their positions in the stock. Quarry LP lifted its position in shares of Phreesia by 210.9% during the 4th quarter. Quarry LP now owns 2,835 shares of the company's stock valued at $71,000 after buying an additional 1,923 shares in the last quarter. Johnson Financial Group Inc. lifted its position in shares of Phreesia by 381.3% during the 4th quarter. Johnson Financial Group Inc. now owns 1,131 shares of the company's stock valued at $28,000 after buying an additional 896 shares in the last quarter. Greenhouse Funds LLLP lifted its position in shares of Phreesia by 27.9% during the 4th quarter. Greenhouse Funds LLLP now owns 2,873,892 shares of the company's stock valued at $72,307,000 after buying an additional 626,579 shares in the last quarter. Hsbc Holdings PLC lifted its position in shares of Phreesia by 36.5% during the 4th quarter. Hsbc Holdings PLC now owns 13,064 shares of the company's stock valued at $333,000 after buying an additional 3,493 shares in the last quarter. Finally, Tower Research Capital LLC TRC lifted its position in shares of Phreesia by 1,023.0% during the 4th quarter. Tower Research Capital LLC TRC now owns 5,660 shares of the company's stock valued at $142,000 after buying an additional 5,156 shares in the last quarter. 92.10% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

PHR has been the topic of several recent analyst reports. Needham & Company LLC reissued a "buy" rating and set a $29.00 target price on shares of Phreesia in a research note on Thursday, March 13th. DA Davidson decreased their target price on Phreesia from $36.00 to $34.00 and set a "buy" rating on the stock in a research note on Monday, April 14th. Piper Sandler reissued an "overweight" rating and set a $33.00 target price (up previously from $31.00) on shares of Phreesia in a research note on Wednesday, January 29th. Canaccord Genuity Group lifted their target price on Phreesia from $34.00 to $35.00 and gave the company a "buy" rating in a research note on Thursday, March 13th. Finally, KeyCorp decreased their target price on Phreesia from $30.00 to $28.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 16th. Twelve research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the stock currently has a consensus rating of "Buy" and an average price target of $31.33.

Insider Activity at Phreesia

In other news, CFO Balaji Gandhi sold 5,771 shares of the stock in a transaction dated Tuesday, February 18th. The stock was sold at an average price of $30.04, for a total value of $173,360.84. Following the transaction, the chief financial officer now directly owns 105,514 shares of the company's stock, valued at approximately $3,169,640.56. This represents a 5.19% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP David Linetsky sold 4,499 shares of the stock in a transaction dated Wednesday, April 16th. The shares were sold at an average price of $23.73, for a total value of $106,761.27. Following the completion of the transaction, the senior vice president now directly owns 217,239 shares in the company, valued at $5,155,081.47. This represents a 2.03% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 55,260 shares of company stock valued at $1,406,251 in the last ninety days. Corporate insiders own 5.80% of the company's stock.

Phreesia Stock Down 0.2%

NYSE:PHR traded down $0.04 during mid-day trading on Monday, hitting $25.36. 369,351 shares of the company's stock traded hands, compared to its average volume of 437,851. The company has a fifty day moving average of $25.29 and a 200 day moving average of $25.03. Phreesia, Inc. has a twelve month low of $17.07 and a twelve month high of $30.53. The company has a market capitalization of $1.51 billion, a P/E ratio of -17.25 and a beta of 0.74. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.74 and a current ratio of 1.74.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.